Skip to main content

Mianserin (International)



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antidepressant, tetracyclic

Antidepressant: α₂-adrenoceptor antagonist

Chemical Name

Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-metyl-

Foreign Names

  • Mianserinum (Latin)
  • Mianserin (German)
  • Miansérine (French)
  • Mianserina (Spanish)

Generic Names

  • Mianserin (OS: BAN)
  • Mianserina (OS: DCIT)
  • Miansérine (OS: DCF)
  • Mianserin Hydrochloride (OS: USAN, JAN, BANM)
  • Org GB 94 (IS)
  • Mianserin Hydrochloride (PH: BP 2018)
  • Mianserin hydrochloride (PH: Ph. Eur. 9)
  • Miansérine (chlorhydrate de) (PH: Ph. Eur. 9)
  • Mianserinhydrochlorid (PH: Ph. Eur. 9)
  • Mianserini hydrochloridum (PH: Ph. Eur. 9)

Brand Names

  • Lantanon
    Organon, Pakistan
  • Miagen 30 mg
    Generics, Hungary
  • Miagen 60 mg
    Generics, Hungary
  • Mianserin Remedica
    Remedica, Cyprus; Remedica, Hong Kong
  • Prevalina
    Laboratorios Andromaco, Chile
  • Seridac
    Zydus, India
  • Tolvon
    Organon, Egypt
  • Athymil
    Organon, Kuwait
  • Bonserin
    Rafa, Israel
  • Depnon
    Organon, India
  • Deprexolet
    Polfa Pabianice, Poland
  • Lantanon
    Frosst SA, Spain; MSD, South Africa; Organon Italia, Italy
  • Lerivon
    MSD, Slovakia; MSD Argentina, Argentina; MSD Belgium, Belgium; Organon, Poland
  • Lerivon 10mg
    MSD Belgium, Luxembourg
  • Lerivon 30mg
    MSD Belgium, Luxembourg
  • Lumin
    Alphapharm, Australia
  • Mealin
    Central Poly, Thailand
  • Miagen 10 mg
    Generics, Hungary
  • Miansec
    PharmaSwiss, Poland
  • Miansegen
    Generics, Poland
  • Mianserin
    Generics UK, United Kingdom; Generics UK, Malta; Remedica, Malta
  • Mianserin Arcana 30 mg
    Arcana Arzneimittel, Austria
  • Mianserin Holsten
    Holsten, Germany
  • Mianserin Mylan
    Mylan, Iceland; Mylan, Norway; Mylan, Sweden
  • Mianserin Orifarm
    Orifarm Generics, Denmark
  • Mianserin-CT
    AbZ-Pharma, Germany
  • Miansérine Arrow
    Arrow, France
  • Miansérine Biogaran
    Biogaran, France
  • Miansérine Cristers
    CristerS, France
  • Miansérine EG
    EG Labo, France
  • Mianserine HCl Teva
    Teva Nederland, Netherlands
  • Miansérine Mylan
    Mylan, France
  • Miansérine RPG
    Ranbaxy, France
  • Miansérine Sandoz
    Sandoz, France
  • Miansérine Teva
    Teva Santé, France
  • Miansérine Zentiva
    Sanofi-Aventis, France
  • Mianserin-Mepha 30mg
    Mepha Pharma, Switzerland
  • Mianserin-Mepha 60mg
    Mepha Pharma, Switzerland
  • Mianserin-neuraxpharm
    neuraxpharm Arzneimittel, Germany
  • Tetradep
    Torrent, India
  • Tetramide
    MSD, Japan
  • Tolimed
    Medifive, Thailand
  • Tolvon
    Aspen Notre Dame de Bondeville, Serbia; M.S.D., Portugal; Merck Sharp & Dohme, Mexico; MSD, Finland; MSD, Norway; MSD Merck Sharp & Dohme, Turkey; N.V. Organon, Netherlands
  • Tolvon (Merck Sharp & Dohme
    China MSD, China
  • Tolvon 30 mg
    MSD, Switzerland; Organon, Austria
  • Tolvon 60 mg
    Organon, Austria


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.